TTNP TITAN PHARMACEUTICALS INC DE

Ownership history in CoreCap Advisors, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which CoreCap Advisors, LLC reported a position in TITAN PHARMACEUTICALS INC DE (TTNP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 88 0% 0.00% $147
2025 Q3 UNCHANGED 88 0% 0.00% $422
2025 Q2 UNCHANGED 88 0% 0.00% $370
2025 Q1 INITIATED 88 0.00% $311
% of Fund (quarterly)
← Back to CoreCap Advisors, LLC Holdings